| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Microbiology and Tumor Biology Center, Karolinska Institutet, Nobels väg 16, S-17177 Stockholm, Sweden
2 Center for Infectious Medicine, Huddinnge Hospital, Karolinska Institutet, Nobels väg 16, S-17177 Stockholm, Sweden
3 Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, UK
4 Department of Microbiology and Immunology, Louisiana State University, Health Science Center, Shreveport, LA, USA
Correspondence
Victor Levitsky
Victor.Levitsky{at}mtc.ki.se
Epstein–Barr virus (EBV) is a ubiquitous human herpesvirus that is involved in the pathogenesis of a wide spectrum of malignant and non-malignant diseases. Strong evidence implicates T lymphocytes in the control of EBV replication and tumorigenesis, but cellular components of the innate immune system are poorly characterized in terms of their function in the development of EBV-specific immunity or interaction with the virus. This study demonstrates that EBV virions produced in epithelial cells surpass their B cell-derived counterparts in the capacity to enter monocytes and inhibit their development into dendritic cells (DCs). Different ratios of the gp42 and gH glycoproteins in the envelope of virions that were derived from major histocompatibility complex class II-positive or -negative cells accounted primarily for the differences in EBV tropism. EBV is shown to enter both monocytes and DCs, although the cells are susceptible to virus-induced apoptosis only if infected at early stages of DC differentiation. The purified gH/gL heterodimer binds efficiently to monocytes and DCs, but not to B cells, suggesting that high expression levels of a putative binding partner for gH contribute to virus entry. This entry takes place despite very low or undetectable expression of CD21, the canonical EBV receptor. These results indicate that the site of virus replication, either in B cells or epithelial cells, alters EBV tropism for monocytes and DCs. This results in a change in the virus's immunomodulating capacity and may have important implications for the regulation of virus–host interactions during primary and chronic EBV infection.
These authors contributed equally to this work.
This article has been cited by other articles:
|
|
 |
|
  Y.-H. Lee, Y.-F. Chiu, W.-H. Wang, L.-K. Chang, and S.-T. Liu Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta J. Gen. Virol., October 1, 2008; 89(10): 2437 - 2446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Hutt-Fletcher Epstein-Barr Virus Entry J. Virol., August 1, 2007; 81(15): 7825 - 7832. [Full Text] [PDF]
|
|
|
|
|
|
R. Hochreiter, C. Ptaschinski, S. L. Kunkel, and R. Rochford Murine gammaherpesvirus-68 productively infects immature dendritic cells and blocks maturation J. Gen. Virol., July 1, 2007; 88(7): 1896 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tugizov, R. Herrera, P. Veluppillai, J. Greenspan, D. Greenspan, and J. M. Palefsky Epstein-Barr Virus (EBV)-Infected Monocytes Facilitate Dissemination of EBV within the Oral Mucosal Epithelium J. Virol., June 1, 2007; 81(11): 5484 - 5496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation J. Virol., May 1, 2007; 81(9): 4389 - 4396. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hahn, L. E. Huye, S. Ning, J. Webster-Cyriaque, and J. S. Pagano Interferon Regulatory Factor 7 Is Negatively Regulated by the Epstein-Barr Virus Immediate-Early Gene, BZLF-1 J. Virol., August 1, 2005; 79(15): 10040 - 10052. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
